Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Biological Research|December 19, 2024
A snapshot of cancer in Chile II: an update on research, strategies and analytical frameworks for equity, innovation and national developmentCristóbal Vacarezza, Julieta Araneda, Pamela Gonzalez, et al.
Cancers|July 16, 2020
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical ApplicabilityMauricio P Pinto, Miguel Córdova-Delgado, Ignacio N Retamal, et al.
JCO Global Oncology|April 24, 2020
Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American RealitiesGermán Calderillo, Matías Muñoz-Medel, Edelmira Carbajal, et al.
Current Research in Microbial Sciences|July 31, 2025
Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19Aldo Barrera, Constanza Martínez-Valdebenito, Bruno Nervi, et al.
Hormones & Cancer|November 23, 2018
Chilean Registry for Neuroendocrine Tumors: A Latin American PerspectiveMauricio P Pinto, Matías Muñoz Medel, Diego Carrillo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 27, 2025
Gallbladder Cancer and Dysplasia in Cholecystectomy Specimens: A Large Study in High-Incidence Regions of South AmericaFelix Boekstegers, Carol Barahona Ponce, Erik Morales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2022
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in ChileM Elvira Balcells, Nicole Le Corre, Josefina Durán, et al.
Lancet Regional Health. Americas|October 3, 2022
SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort studyMartín Dib, Nicole Le Corre, Catalina Ortiz, et al.
Plos Medicine|March 3, 2021
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trialMaría Elvira Balcells, Luis Rojas, Nicole Le Corre, et al.
Pageof 7